PTC Therapeutics
PTCT
#3019
Rank
NZ$9.74 B
Marketcap
NZ$116.67
Share price
1.20%
Change (1 day)
-10.59%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: NZ$9.74 Billion

As of November 2026 PTC Therapeutics has a market cap of NZ$9.74 Billion. This makes PTC Therapeutics the world's 3019th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$9.74 B-10.5%
2025NZ$10.89 B76.08%
2024NZ$6.18 B88.08%
2023NZ$3.28 B-25.04%
2022NZ$4.38 B6.42%
2021NZ$4.12 B-28.57%
2020NZ$5.77 B30.67%
2019NZ$4.41 B70.59%
2018NZ$2.58 B165.72%
2017NZ$0.97 B80.28%
2016NZ$0.54 B-66.34%
2015NZ$1.60 B-26.14%
2014NZ$2.17 B342.21%
2013NZ$0.49 B

End of Day market cap according to different sources

On Nov 11th, 2026 the market cap of PTC Therapeutics was reported to be:

NZ$9.74 Billion
by Nasdaq info icon info icon
NZ$9.74 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$544.22 B 5,483.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$249.28 B 2,457.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$5.39 B-44.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.21 B-67.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.35 B-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$20.21 B 107.44%๐Ÿ‡บ๐Ÿ‡ธ USA